Global Clinical Laboratory Tests Market

Global Clinical Laboratory Tests Market Size, Share, Growth Analysis, By Type (Complete Blood Count, HGB/ HCT testing), By End-use(Central Laboratories, and Primary Clinics) - Industry Forecast 2024-2031


Report ID: SQMIG35I2276 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 70 | Figures: 75

Global Clinical Laboratory Tests Market Insights

Clinical Laboratory Tests Market size was valued at USD 94.76 Billion in 2021 and is poised to grow from USD 103.67 billion in 2022 to USD 212.71 billion by 2030, growing at a CAGR of 9.4% during the forecast period (2023-2030).

The market for clinical laboratories is growing as a result of the aging of the population, the rise of target illness cases, and the development of innovative solutions to meet the market's rising need for clinical testing. The medical and testing sectors have been greatly impacted by COVID-19's ubiquitous availability. Clinical laboratory test demand has been negatively impacted by the pandemic. The widespread availability of COVID-19 has significantly impacted the healthcare and testing industries. The pandemic's negative consequences have been seen in the market for clinical laboratory tests. This is also due to the fact that fewer people underwent routine medical examinations overall during the pandemic, which decreased the amount of clinical chemical tests performed. The number of tests performed has since returned to normal, though, suggesting that the COVID-19 pandemic had no lasting negative effects on the market.

The WHO reports that in the majority of industrialized economies, the average life expectancy has surpassed 80 years. Aging is characterized as a significant risk factor for the emergence of infectious diseases due to the interaction of various genetic and environmental variables that impact immunity and metabolism, changing the function of organs. Therefore, diagnostics and screening might be crucial in the treatment of general health. Therefore, as the elderly population grows, so does the demand for acute & long-term healthcare, fueling the expansion of the global market.

Furthermore, it is anticipated that the development of novel approaches to maximizing effectiveness and minimizing errors would significantly boost the performance of this industry. With businesses processing as much as 100 to 150 billion samples annually, integrated flow management platforms, database management tools, & patient test records are becoming more and more important in the healthcare sector. This market's expansion is anticipated to be fueled by the execution and growth of data management & informatics solutions for aiding efficient operations.

However, the regulatory environment surrounding clinical laboratory tests is unclear, which limits market growth. The U.S. FDA and the European Medicines Agency (EMA), for example, have built regulatory frameworks that are heavily reliant on by the healthcare sector. In emerging nations like China and India, the diagnostic industry is not subject to any clear regulatory standards. Laboratory-developed testing that refers to providing accurate and speedy results and internal clinical laboratories creating tests are subject to FDA regulation. Profit margins may suffer as a result of LDT risks, and the launch of newly developed tests may be delayed.

US Clinical Laboratory Tests Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Clinical Laboratory Tests Market size was valued at USD 94.76 Billion in 2021 and is poised to grow from USD 103.67 billion in 2022 to USD 212.71 billion by 2030, growing at a CAGR of 9.4% during the forecast period (2023-2030).

The major players in the clinical laboratory test industry are continually working to improve patient outcomes and the effectiveness and effectiveness of healthcare by introducing new technologies and altering those that already exist. For instance, Omega Laboratories will begin conducting urine tests as part of its new Urine Drugs of Use Testing Services in December 2022, complementing its DNA testing in Canada. 'Quest Diagnostics Incorporated', 'Laboratory Corporation of America Holdings (LabCorp)', 'Siemens Healthineers AG', 'Roche Diagnostics', 'Abbott Laboratories', 'Thermo Fisher Scientific Inc.', 'Bio-Rad Laboratories, Inc.', 'Danaher Corporation', 'Sysmex Corporation', 'Becton, Dickinson and Company (BD)', 'bioMérieux SA', 'Agilent Technologies, Inc.', 'Genomic Health, Inc.', 'Myriad Genetics, Inc.', 'Cepheid (a subsidiary of Danaher Corporation)', 'QIAGEN N.V.', 'Hologic, Inc.', 'Ortho Clinical Diagnostics', 'PerkinElmer, Inc.', 'GenMark Diagnostics, Inc.'

The growing prevalence of chronic diseases and infectious diseases worldwide is driving the demand for clinical laboratory tests. These tests play a crucial role in disease diagnosis, monitoring, and treatment.

Increasing Demand for Molecular Diagnostics: There is a growing demand for molecular diagnostic tests that can detect genetic variations, infectious diseases, and other biomarkers at the molecular level. Advances in genomics and targeted therapies have led to the integration of molecular diagnostics into routine clinical practice.

North America dominated the market in terms of share in 2022, and it is anticipated that it will continue to do so during the forecast period. This might be linked to the region's growing senior population, increased chronic illness prevalence, including cancer, and strong market penetration of cutting-edge diagnostic techniques. One of the primary cause’s deaths in North America, reported to the American Cancer Society as a whole, is cancer. Prostate cancer in males and cancer of the breast in women are the two cancers that are most frequently diagnosed. The regional market is anticipated to be driven by factors like rising patient awareness and growing inclination for novel techniques.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Clinical Laboratory Tests Market

Product ID: SQMIG35I2276

$5,300
BUY NOW GET FREE SAMPLE